SCHEMBL8907011

SCHEMBL8907011

[O]CCOCCc1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
HSD17B10 Q99714 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
LMNA P02545 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TAAR1 Q96RJ0 1/20 0.44
ALOX15 P16050 1/20 0.44
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7449287 0.90 HRH1 (0.59) HRH1CA12CA1CA2CA9
SCHEMBL8906069 0.89 HRH1 (0.50) HRH1CA12CA1CA2CA9
SCHEMBL27263449 0.87 HRH1 (0.52) HRH1CA12CA1CA2CA9
SCHEMBL8904860 0.83 SMN1; SMN2 (0.47) HRH1CA12CA1CA2CA9
SCHEMBL24762639 0.81 CA12 (0.54) HRH1CA12CA1CA2CA9
SCHEMBL18163287 0.81 ABCB1 (0.51) HRH1CA12CA1CA2CA9
SCHEMBL1826443 0.81 HRH1 (0.50) HRH1CA12CA1CA2CA9
SCHEMBL29436004 0.80 CA12 (0.49) HRH1CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL10390264 0.80 CA12 (0.53) HRH1CA12CA1CA2CA9
Ammonia Solution, Strong SCHEMBL27690821 0.80 CA12 (0.53) HRH1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5659065-A CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS NOVARTIS CORPORATION (US) 1997-08-19 US disclosed
EP-0678500-A1 Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors CIBA-GEIGY AG (CH) 1995-10-25 EP disclosed